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Metazoan replication-dependent histone mRNAs end in a conserved stem-loop rather than in the poly(A) tail
found on all other mRNAs. The 3 end of histone mRNA binds a single class of proteins, the stem-loop binding
proteins (SLBP). In Xenopus, there are two SLBPs: xSLBP1, the homologue of the mammalian SLBP, which is
required for processing of histone pre-mRNA, and xSLBP2, which is expressed only during oogenesis and is
bound to the stored histone mRNA in Xenopus oocytes. The stem-loop is required for efficient translation of
histone mRNAs and substitutes for the poly(A) tail, which is required for efficient translation of other
eucaryotic mRNAs. When a rabbit reticulocyte lysate is programmed with uncapped luciferase mRNA ending
in the histone stem-loop, there is a three- to sixfold increase in translation in the presence of xSLBP1 while
xSLBP2 has no effect on translation. Neither SLBP affected the translation of a luciferase mRNA ending in a
mutant stem-loop that does not bind SLBP. Capped luciferase mRNAs ending in the stem-loop were injected
into Xenopus oocytes after overexpression of either xSLBP1 or xSLBP2. Overexpression of xSLBP1 in the
oocytes stimulated translation, while overexpression of xSLBP2 reduced translation of the luciferase mRNA
ending in the histone stem-loop. A small region in the N-terminal portion of xSLBP1 is required to stimulate
translation both in vivo and in vitro. An MS2-human SLBP1 fusion protein can activate translation of a
reporter mRNA ending in an MS2 binding site, indicating that xSLBP1 only needs to be recruited to the 3 end
of the mRNA but does not need to be directly bound to the histone stem-loop to activate translation.
Replication-dependent histone mRNAs are unique among
metazoan mRNAs because they are not polyadenylated but
end, instead, in a highly conserved stem-loop (35). In contrast,
histone mRNAs from fungi and plants are polyadenylated.
Histone pre-mRNA processing requires only a single endonu-
cleolytic cleavage to form the 3 end of the mature mRNA
immediately after a highly conserved stem-loop structure (16).
Most of the regulation of histone mRNA levels is mediated by
the stem-loop and occurs at the posttranscriptional level, via
regulation of mRNA processing and stability (22, 44). It is
likely that the stem-loop also fulfills the essential functions that
are performed by the poly(A) tail on other mRNAs. One of
these functions is to enhance the efficiency of translation (27,
52). For example, the stem-loop has been shown to promote
localization of histone mRNAs to polyribosomes (56). mRNAs
ending in the histone stem-loop at the 3 end are translation-
ally more active than messages ending in other stem-loops
when transfected into Chinese hamster ovary cells (15).
By using the yeast three-hybrid system, proteins that bind to
the stem-loop have been isolated from several species (34, 55,
64, 66). Although only a single SLBP is present in mammals
(34, 66), Drosophila (55), and Caenorhabditis elegans, frog oo-
cytes (46) express two SLBPs, called xSLBP1 and xSLBP2 (64).
The centrally located RNA binding domain (RBD) is highly
conserved between xSLBP1 and xSLBP2 (64). The two frog
SLBPs otherwise are not similar in structure, suggesting that
they may have distinct activities in histone mRNA metabolism.
xSLBP2 is expressed only during oogenesis and is confined to
the cytoplasm (64). xSLBP1 is the orthologue of the human
and mouse SLBPs that regulate replication-dependent histone
mRNA metabolism (69). xSLBP1 is expressed throughout de-
velopment and is located both in the nucleus and in the cyto-
plasm (64).
Translation in eucaryotes is accomplished by a number of
trans-acting factors that interact with the 5 end of polyadenyl-
ated mRNAs (reviewed in references 17, 23, and 52). Initiation
factor eIF-4E binds the m7G(5)ppp(5)N cap structure. Initi-
ation factor eIF-4G is associated with the 5 end of the mes-
sage via its interaction with eIF-4E and also serves as a scaffold
protein for binding of eIF3. eIF-4A, an RNA helicase, also
binds to eIF-4G and, together with eIF-4E, makes up the
eIF-4F complex. The 40S ribosomal subunit is bound to the
mRNA 5 end by virtue of its interaction with eIF3. This
binding promotes proper localization of the preinitiation com-
plex, allowing recruitment of the initiator tRNA and also is
necessary for joining of the 60S and 40S subunits.
Recently, it has been shown that the 3 untranslated region
(UTR) of many mRNAs contains sequence elements required
for regulation of translation (8, 9, 43, 50, 75). The 3 end of
mRNA participates synergistically with the 5 end in transla-
tion of polyadenylated mRNAs (14). The poly(A) tail, which is
usually 50 to 200 residues long, binds to the poly(A) binding
protein (PABP). PABP mediates bridging of the 5 and 3 ends
of the message by interacting directly with eIF-4G (25, 29, 59,
60, 68). It is believed that the resulting circular mRNP struc-
ture promotes translation reinitiation by keeping the ribo-
somes that are coming off the 3 end of the message in close
proximity to the 5 initiation site (27). There is also evidence
that PABP enhances binding of eIF-4E to the cap structure,
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promoting the initial rounds of translation (6, 67). By binding
to the poly(A) tail and the cap/eIF-4F complex, PABP may
also help protect both ends of the mRNA from degradation (5,
68). Degradation of the polyadenylated mRNAs may require
breaking of the interaction between the 3 and 5 ends of the
message (4, 61), allowing decapping of the mRNA, which is
often followed by 5-to-3 degradation.
Histone mRNA and protein synthesis occurs very early dur-
ing oogenesis in Xenopus laevis and is completed by the end of
stage II (1, 72). The histone mRNA is then stored in an inac-
tive form for the remainder of oogenesis, while the histone
protein is stored in the germinal vesicle complexed with acidic
proteins, nucleoplasmin and N1/N2 (11). During late oogenesis
(stages IV to VI), when no histone protein synthesis is occur-
ring, the bulk of the histone mRNA is bound to xSLBP2 and
only 10% can be immunoprecipitated with anti-xSLBP1 anti-
bodies (64). Translation of histone mRNA is reactivated at
oocyte maturation (1), which can be induced by treatment of
stage VI oocytes with progesterone. During oocyte maturation,
xSLBP2 is degraded and xSLBP1 then binds to the histone
mRNA (64). These observations suggest that regulation of
histone message translation may depend on which xSLBP is
bound to the stem-loop and that xSLBP1 may actively promote
histone mRNA translation.
Here we report that xSLBP1, but not xSLBP2, can stimulate
translation of a luciferase mRNA that ends in the histone
stem-loop in vitro and in vivo. A 10- to 15-amino-acid region in
the N-terminal portion of xSLBP1 is responsible for translation
activation. These data provide direct evidence that the trans-
lation of histone mRNA in Xenopus oocytes is controlled by
the two xSLBPs: xSLBP2, a histone mRNA-specific masking
factor, and xSLBP1, a histone mRNA-specific translation ac-
tivator.
MATERIALS AND METHODS
Construction of SLBP variants. All of the SLBPs were expressed from the
modified p64T vector pXFRM, previously described, which provides 5 and 3
-globin UTRs and a poly(A) tail for efficient translation of in vitro-transcribed
RNA in oocytes (26, 64). The chimeric SLBPs were constructed as described
previously (26). We have recently determined that xSLBP2 contains an addi-
tional 23 amino acids at the amino terminus compared to the xSLBP2 sequence
previously reported (64) (accession no. AF106799); these additional amino acids
were introduced by PCR into the xSLBP2 expression vector. The original
xSLBP2 cDNA from the two-hybrid vector pGAD10 was used as the template;
the forward primer was used to introduce a BspHI site that contains the new
initiation codon at the beginning of xSLBP2. The resulting PCR product was
digested with BspHI and XbaI and subcloned into pXFRM digested with NcoI
and XbaI.
Mutant forms xSLBP65-69/5A, xSLBP70-74/5A, xSLBP75-79/5A, xSLBP80-84/5A,
and xSLBP85-89/5A were generated by PCR with xSLBP1 as the template. The 5
end of the forward and reverse primers started with the sequences CAGCAGCA
and CTGCTGC, respectively, which together resulted in a substitution of five
alanines. The xSLBP1 deletion mutant forms 68-1-1, 68-1-0, 81-1-1, 81-1-0,
1-1-0, and 13 were generated by PCR with xSLBP1 as the template. Human
SLBP (hSLBP) and the mutant forms hSLBPRR/KK and hSLBPYY/SS were con-
structed as described previously (12).
The MS2 and MS2-hSLBP vectors were generated by subcloning of the MS2
coding sequence from a vector provided by Joseph Viradell (Albert Einstein
School of Medicine) into the pFastBac-HTa vector (HTa-MS2). Human SLBP
was subcloned into HTa-MS2 from the previously described pXFRM-hSLBP
vector (12). The MS2 and MS2-hSLBP coding sequences were subcloned into
pXFRM from vectors HTa-MS2 and HTa-MS2-hSLBP.
Construction of reporter mRNAs. The Luc-polyA, Luc-SL, and Luc-TL con-
structs, in which the firefly luciferase coding region is under the control of the T7
promoter, have been described previously (15). The pRL-CMV vector (Pro-
mega) was used as a template to amplify the Renilla luciferase coding region by
PCR. An NcoI site was introduced at the initiation codon. After digestion with
NcoI and XbaI, the Renilla PCR product was subcloned into the homologous
sites in the Luc-SL vector to generate the R-Luc-SL vector. The polyadenylated
chloramphenicol acetyltransferase (CAT-A50) coding region, previously sub-
cloned into pBluescript II (Stratagene), was digested with HindIII and EcoRI
and subcloned into pGEM-3Zf (Promega). To generate the Luc-MS2 vector, two
complementary oligonucleotides encoding the MS2 binding site were annealed
and ligated into the Luc-SL vector digested with BamHI and AflII.
In vitro transcription. SLBP plasmids were linearized with EcoRI and tran-
scribed with SP6 RNA polymerase in the presence of a cap analogue (New
England Biolabs). The luciferase plasmids with different 3 ends were linearized
with AflII (R-Luc-SL, Luc-SL, Luc-TL, and Luc-MS2) prior to transcription with
T7 RNA polymerase (New England Biolabs) in the presence or absence of the
cap analogue (15). The CAT-A50 and Luc-polyA plasmids were linearized with
NdeI prior to transcription with T7 RNA polymerase. Transcription reaction
mixtures were treated with RQ1 DNase (Promega), and the RNA was purified
on G-50 microcolumns (Pharmacia).
In vitro translation. Plasmids encoding SLBP, MS2, and MS2-hSLBP under
control of the SP6 promoter in the pXFRM vector (64) (final concentration, 20
ng/l) were incubated for 1 h in a micrococcal nuclease-treated transcription-
translation coupled rabbit reticulocyte lysate (RRL) system (Promega) in the
presence of SP6 RNA polymerase and [35S]methionine. A fraction of this reac-
tion mixture (5 l) was added to a mixture (10 l) containing fresh micrococcal
nuclease-treated RRL, [35S]methionine, uncapped CAT-A50 mRNA (20 ng/l),
and one of the firefly luciferase uncapped transcripts (20 ng/l). After incubation
at 30°C for 1 h, the in vitro translation reaction mixture was resolved by sodium
dodecyl sulfate (SDS)–10% polyacrylamide gel electrophoresis (PAGE) and
protein synthesis was quantified on a Storm 840 PhosphorImager with the Im-
ageQuant program (Molecular Dynamics).
Injection of oocytes. Ovaries were removed from adult female frogs (NASCO)
and treated for 2 h in 0.2% collagenase in OR-2 solution at 27°C. After removal
of the collagenase, the oocytes were allowed to recover at 18°C in OR-2 solution
for at least 24 h. Stage VI oocytes were injected in the cytoplasm with 30 nl of
capped SLBP mRNAs (50 ng/l) and incubated in OR-2 solution for 8 to 16 h
at 18°C. Control oocytes were injected with 30 nl of water. Capped firefly and
Renilla luciferase mRNAs were injected in the cytoplasm (30 nl, 50 ng/l,
equimolar concentrations) and harvested 12 h later. Twelve to 15 oocytes were
pooled for each experiment. The oocytes were homogenized (2.5 l per oocyte)
in 20 mM Tris (pH 7.5)–1 mM phenylmethylsulfonyl fluoride (Invitrogen)–1
protease inhibitor cocktail (Sigma). These lysates were then used for RNA
preparation, mobility shift assays, luciferase assays, and Western blotting.
Luciferase assay. Luciferase was measured with a Monolight 2010 luminom-
eter (Analytical Luminescence Laboratory) after dilution of the in vitro transla-
tion reaction mixture in 1 luciferase lysis buffer 1/25 (Analytical Luminescence
Laboratory). Lysates equivalent to two oocytes were diluted in 1 passive lucif-
erase buffer 1/25 (Promega). Renilla and firefly luciferase activities were mea-
sured with a dual luminometer (Lmax; Molecular Devices).
RNA extraction and analysis. Total RNA was extracted from oocyte lysates
with Trizol reagent (Invitrogen) and 1 oocyte equivalent of total RNA was
hybridized to 5 ng of probe. The S1 probe used to determine luciferase RNA
levels was generated by linearization of the Luc-SL vector with DraII, which cuts
in the luciferase coding region. The 3 end was labeled with the Klenow fragment
of DNA polymerase I (New England Biolabs) and [-32P]dCTP. Hybridization
was done at 56°C, and S1 digestion was performed as previously described (12,
18). The protected fragments were resolved on a 10% polyacrylamide–7 M urea
gel and detected by autoradiography.
Antibodies. The RBD was deleted by PCR from the glutathione S-transferase
(GST)-xSLBP2 fusion protein (64) to give the GST-xSLBP2-RBD fusion pro-
tein. xSLBP2 antibodies were purified as previously described, with the
GST-xSLBP2-RBD fusion protein expressed in bacteria (64). Antibodies gener-
ated against xSLBP1 expressed in baculovirus were affinity purified with immo-
bilized full-length xSLBP1.
Western blot assays. The lysate from four oocytes was diluted in 0.5 ml of 20
mM Tris (pH 7.5)–1 mM phenylmethylsulfonyl fluoride (Invitrogen)–1 pro-
tease inhibitor cocktail (Sigma) and centrifuged for 5 min at 14,000 rpm in an
Eppendorf microcentrifuge. The clear supernatant was precipitated with 1 ml of
acetone and centrifuged for 15 min at 14,000 rpm. The pellet was resuspended in
1% SDS–5% glycerol–0.06 M Tris (pH 6.8)–5% -mercaptoethanol and boiled;
proteins were resolved by SDS–10% PAGE and transferred to nitrocellulose.
The filter was incubated with the appropriate affinity-purified antibody, and the
bound antibodies were detected by chemiluminescence with SuperSignal
(Pierce).
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Mobility shift assay. Oocyte lysate equivalent to one oocyte was mixed on ice
with buffer (final concentrations: 70 mM KCl, 14 mM HEPES [pH 7.9], 150 mM
EDTA [pH 8.0], 7% glycerol, 5 mM dithiothreitol, and 1 g of tRNA per l) and
5 ng of a 30-nucleotide (nt) synthetic radiolabeled stem-loop RNA that was
prepared as previously described (70). The complexes were resolved on a 10%
native polyacrylamide gel and were visualized by autoradiography.
RESULTS
Since SLBP is the only known protein that specifically binds
the 3 end of histone mRNA, it is an obvious candidate to
mediate the effect of the stem-loop on translation of histone
mRNA. There are two SLBPs in frog oocytes, each of which
binds the stem-loop with similar affinity (26, 64). Each of these
proteins consists of about 280 amino acids, with the RBD
located in the center of the protein.
Only xSLBP1 activates translation of Luc-SL mRNA in
vitro. To investigate the possible role of SLBP in translation,
we used both an in vitro system, the RRL, and an in vivo
system, injection of reporter mRNAs into Xenopus oocytes.
We used three reporter luciferase mRNAs, which are shown in
Fig. 1A. The first (Luc-SL) ends in the histone stem-loop, the
second (Luc-TL) ends in a GNRA tetraloop that contains the
same stem and flanking sequences as the histone stem-loop but
that does not bind SLBP, and the third (Luc-polyA) ends in a
50-nt poly(A) tail. We also used an mRNA encoding the Re-
nilla luciferase that ended in a histone stem-loop (R-Luc-SL)
as an internal control for the in vivo experiments. We deter-
mined the effect of expression SLBPs on the translation of the
various reporter luciferase mRNAs in vitro and in vivo.
A schematic of the in vitro assay is shown in Fig. 1B. Briefly,
xSLBP1, xSLBP2, or any one of various chimeric or mutated
proteins was first expressed in an RRL. This served as the
FIG. 1. SLBP stimulates histone mRNA translation in vitro. (A) Structure of the 3 end of the luciferase reporter mRNAs. The Luc-SL mRNA
ends in the histone stem-loop that binds SLBP, the Luc-TL mRNA ends in a stem-loop that does not bind SLBP, and the Luc-polyA mRNA ends
in a poly(A) tail 50 nt long. ORF, open reading frame. (B) Schematic of the in vitro translation assay. An aliquot of RRL was incubated either
with buffer or with SLBP DNA in the presence of T7 RNA polymerase and [35S]methionine. After incubation for 90 min, an aliquot of the lysate
was mixed with a fresh aliquot of reticulocyte lysate together with a luciferase uncapped reporter mRNA and a polyadenylated uncapped CAT
mRNA as an internal standard. After incubation for 90 min at 30°C, the reaction products were analyzed by SDS-PAGE and the in vitro-
synthesized proteins were detected by autoradiography. An aliquot of the assay was analyzed for luciferase activity by luminometry. (C) Lysates
containing no SLBP (lanes 1 to 3), xSLBP2 (lanes 4 to 6), or xSLBP1 (lanes 7 to 9) were incubated with the standard polyadenylated CAT mRNA
and the Luc-TL (lanes 1, 4, and 7), Luc-SL (lanes 2, 5, and 8), or Luc-polyA (lanes 3, 6, and 9) mRNA. The reaction products were analyzed by
gel electrophoresis, and the proteins were detected by autoradiography. (D) The autoradiogram (panel C) was quantified, and relative luciferase
activity was calculated. In addition, an aliquot of each reaction mixture was analyzed for luciferase activity with a luminometer. Quantification of
the results by PhosphorImager and by luciferase assay yielded identical results. Panel D shows the results of an average of five experiments with
five different batches of RRL, and the error bars represent the standard deviation. The fold activation is the result of luciferase activity from the
Luc-SL and Luc-polyA mRNAs divided by the luciferase activity from the Luc-TL mRNA.
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source of SLBP for the in vitro assays. After incubation for 90
min, equal amounts of these lysates were added to a translation
reaction mixture containing uncapped, polyadenylated CAT
mRNA and a luciferase reporter mRNA, also uncapped. Thus,
within each experiment, the different reporter mRNAs were
tested with the same amount and preparation of SLBP.
The reticulocyte lysate contains very small amounts of SLBP
(66). Expression of SLBP in the lysate from synthetic mRNA
results in the synthesis of sufficient SLBP to bind exogenous
stem-loop RNA in a mobility shift assay (12, 66). Enough
SLBP is produced by this approach to bind all of the reporter
mRNAs added to the lysate. Since the reticulocyte lysate
largely responds to the cap at the 5 end of the mRNA, we used
uncapped mRNAs in these experiments. There was no effect of
any of the proteins (or different 3 ends) when we used capped
mRNAs expressed from the same constructs (data not shown).
We included an uncapped polyadenylated CAT mRNA both to
provide an internal control for translation efficiency and as a
competitor for translation initiation factors to maximize the
effect of the 3 end of the luciferase mRNA (49). We analyzed
the expression of the xSLBPs, CAT, and luciferase proteins by
gel electrophoresis, followed by autoradiography (Fig. 1C). We
also assayed luciferase activity with a luminometer (Fig. 1D).
We first tested the effects of xSLBP1 and xSLBP2 on the
translation of the Luc-SL, Luc-TL, and Luc-polyA mRNAs in
vitro. When either buffer or in vitro-synthesized xSLBP2 was
added to the reticulocyte lysate containing different reporter
mRNAs, the Luc-SL and Luc-TL mRNAs were translated with
similar efficiencies (Fig. 1C, lanes 1 and 2 and 4 and 5, respec-
tively). The Luc-polyA mRNA was translated about 20-fold
more efficiently than the mRNAs ending in a stem-loop (Fig.
1C, lane 3). In the presence of xSLBP2, the absolute amounts
of translation of all of the mRNAs (including the CAT com-
petitor) were reduced (Fig. 1C, lanes 4 to 6) because of the
presence of the additional competitor SLBP mRNA. The rel-
ative amounts of luciferase expression compared to CAT ex-
pression determined by PhosphorImager analysis was essen-
tially the same for all three luciferase mRNAs (Fig. 1C, lanes
1 to 3 versus lanes 4 to 6). In contrast, when xSLBP1 was
included in the final reaction mixture, there was a four- to
fivefold increase in the translation of the Luc-SL mRNA (Fig.
1C, lane 8 versus lane 5), relative to the Luc-TL mRNA. There
was no change in the translation of the Luc-polyA mRNA
relative to that of the Luc-TL mRNA in the presence of xS-
LBP2 (Fig. 1C, lanes 4 and 6) or xSLBP1 (Fig. 1C, lanes 7 and
9).
To determine whether the effect of xSLBP1 was dependent
on the interaction of xSLBP1 with the stem-loop, we replaced
xSLBP1 with in vitro-synthesized hSLBP (the orthologue of
xSLBP1) or two hSLBP mutant forms (hSLBPRR/KK and
hSLBPYY/SS, Fig. 2A). Addition of hSLBP stimulated transla-
tion of the Luc-SL mRNA four- to fivefold, the same level as
xSLBP1 (Fig. 1D). In the mutants, two conserved arginines at
positions 10 and 11 in the RBD were replaced with lysines
(hSLBPRR/KK) or the tyrosines at positions 24 and 27 were
replaced with two serines (hSLBPYY/SS). Neither of these pro-
teins binds the stem-loop with high affinity, as determined by
mobility shift assay (12). Both hSLBPRR/KK and hSLBPYY/SS
failed to stimulate translation of the Luc-SL mRNA (Fig. 2A).
Competition experiments were also carried out to demon-
strate that SLBP must bind the Luc-SL mRNA to stimulate
translation. Short, uncapped RNA oligoribonucleotides con-
taining either the stem-loop (SL) or the reverse stem (RS),
which does not bind SLBP (45, 70), were added together with
Luc-SL or Luc-TL mRNA to the translation reaction mixtures
supplemented with xSLBP1. A 100-fold molar excess of the
30-mer SL RNA effectively inhibited the stimulation of trans-
lation of Luc-SL mRNA in the reaction mixtures containing
xSLBP1 (Fig. 2B). Addition of a 200-fold molar excess of the
RS oligoribonucleotide had no affect on the stimulation of
translation of Luc-SL mRNA (Fig. 2B). Neither competitor
oligoribonucleotide had any effect on the translation of the
Luc-TL mRNA (Fig. 2B). We conclude that the stimulation of
the translation of Luc-SL mRNA requires that it form a com-
plex with xSLBP1.
xSLBP1 activates translation of Luc-SL mRNA in vivo. We
also tested whether xSLBP1 could stimulate translation in vivo
by injecting similar reporter mRNAs into Xenopus oocytes
after overexpression of different SLBPs in vivo. In this case, the
reporter mRNAs were capped (since uncapped mRNAs are
very unstable in the oocytes) but they were otherwise identical
to the three mRNAs used in the in vitro studies (Fig. 1A). To
allow us to readily measure the relative translation of two
different mRNAs in the same oocytes, we constructed a re-
porter mRNA that encoded the Renilla luciferase (R-Luc-SL)
FIG. 2. SLBP must bind mRNA to stimulate translation. (A) Ly-
sates containing hSLBP or two mutant hSLBPs that do not bind the
stem-loop were incubated with the standard polyadenylated CAT
mRNA and the Luc-TL or Luc-SL mRNA and assayed for luciferase
activity. hSLBPRR/KK has arginines 10 and 11 in the RBD changed to
lysines, and hSLBPYY/SS has tyrosines 24 and 27, also in the RBD,
changed to serines (12). (B) Lysates containing xSLBP1 were incu-
bated with the standard polyadenylated CAT mRNA and the Luc-TL
or Luc-SL mRNA in the presence of either excess 30-nt RNA con-
taining the histone stem-loop (SL) or with the reverse stem-loop (RS)
and then assayed for luciferase activity.
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in addition to the reporter mRNAs encoding firefly luciferase.
We then independently assayed the Renilla luciferase and fire-
fly luciferase activities from the same samples, providing an
internal control for the activity of the reporter mRNAs (39,
74).
Stage VI oocytes were injected (T0, Fig. 3A) in the cyto-
plasm with capped mRNA encoding an SLBP or with buffer.
Synthesis of SLBP was allowed to proceed for 12 to 16 h prior
to cytoplasmic injection of equimolar amounts of the different
capped firefly luciferase reporter mRNAs and the R-Luc-SL
mRNA at time T1. At time T2, 12 to 16 h after injection of the
reporter mRNAs, the oocytes were harvested. The activities of
the two luciferases were measured by luminometry, and the
SLBP levels were measured by Western blotting and, in some
cases, by mobility shift assay. For each experiment shown, the
same batch of oocytes was used. There was variability in the
magnitude of the activation observed among different batches
of oocytes, but the qualitative effects of the SLBPs were iden-
tical.
To control for the stability of the mRNAs, we measured the
level of luciferase mRNAs by S1 nuclease protection at the end
of the incubation (see Fig. 7D). The ability of each of these
reporter mRNAs (which were capped) to program luciferase
activity in the reticulocyte lysate was also determined. All three
reporter mRNAs had similar activities in the absence of com-
petitor mRNAs or SLBPs, since the cap dominates the in vitro
translation activity (data not shown) (14, 40).
We tested the effect of increased expression of xSLBP1 or
xSLBP2 in vivo on the translation of the three luciferase re-
porter mRNAs. The xSLBP1 and xSLBP2 protein levels (mea-
sured by Western blotting) were each increased more than
fivefold over endogenous levels after injection of the SLBP
mRNA (Fig. 3B). The exogenous SLBPs persisted at the same
levels at the end of the incubation, regardless of the nature of
the luciferase transcripts injected at T1 (Fig. 3B, lanes 3 and 4
and 7 and 8). We measured the activities of both the Renilla
and firefly luciferases and normalized the firefly luciferase ac-
tivity from each reporter mRNA by adjusting to a constant
amount of Renilla luciferase activity. We then set the firefly
luciferase activity observed with the Luc-TL mRNA at 1 and
expressed the activity of the Luc-SL and Luc-polyA mRNAs
relative to the activity of the Luc-TL mRNA.
There is some free xSLBP1 and xSLBP2 present in the
cytoplasm of Xenopus oocytes, as assayed by mobility shift
assay, with a larger amount of free xSLBP1 (64). Thus, when
the reporter mRNAs are injected into oocytes without expres-
sion of exogenous SLBPs, the activity measured is affected by
the presence of the endogenous SLBPs. Figure 3C shows a
time course of the relative expression of the reporter mRNAs
following injection at T1 into the cytoplasm of oocytes that had
previously been injected at T0 with buffer (top), xSLBP1
mRNA (middle), or xSLBP2 mRNA (bottom). In oocytes in-
FIG. 3. SLBP stimulates translation of Luc-SL mRNA in vivo.
(A) Schematic of the in vivo assay. Xenopus oocytes were injected
either with buffer or with a synthetic mRNA encoding an SLBP (T0).
At 12 to 16 h later (T1), the oocytes were injected with the reporter
firefly luciferase mRNA (Luc-test) mixed with a synthetic mRNA
encoding Renilla luciferase ending in the histone stem-loop (R-Luc-
SL). After incubation for an additional 12 to 16 h (T2), the oocytes
were harvested and assayed for both luciferase activity and SLBP
expression by Western blotting and by mobility shift assay with a
radiolabeled stem-loop as the probe. The stability of reporter mRNAs
was determined by S1 nuclease protection with a radiolabeled DNA
fragment complementary to the 3 end of the Luc-SL mRNA. (B) Oo-
cytes were injected at T0 with buffer (lanes 3, 4, 7, and 8) or with
xSLBP1 (lanes 1and 2) or xSLBP2 (lanes 5 and 6) and then at T1 with
either the Luc-SL mRNA (lanes 1, 3, 5, and 7) or Luc-TL mRNA
(lanes 2, 4, 6, and 8), together with R-Luc-SL mRNA. Oocytes were
collected and lysed 8, 16, and 24 h later (T2  8, 16, and 24 h). Total
oocyte protein was resolved by gel electrophoresis, transferred to ni-
trocellulose, and xSLBP1 (lanes 1 to 4) or xSLBP2 (lanes 5 to 8) was
detected with appropriate antibodies. Panel B shows the Western
blots of samples collected at T2  16 h. (C) Oocytes were injected
with buffer (top), xSLBP1 mRNA (middle), or xSLBP2 mRNA (bot-
tom). After 16 h, the oocytes were injected with the R-Luc-SL mRNA
together with the Luc-SL, Luc-TL, or Luc-polyA mRNA. At 8, 16, or
24 h later, oocytes were harvested and assayed for Renilla and firefly
luciferase activities. The ratio of Luc-TL luciferase activity to Renilla
luciferase activity was determined, and this value was set at 1. The
activity of the Luc-SL and Luc-polyA mRNAs was expressed relative
to that of the Luc-TL mRNA.
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jected with buffer, translation of Luc-SL mRNA was two- to
threefold greater than translation of Luc-TL mRNA (Fig. 3C,
top). The Luc-polyA mRNA was translated two to three times
better than the Luc-SL mRNA and six- to eightfold better than
the Luc-TL mRNA. This stimulation of translation of the
Luc-SL mRNA is likely due to the endogenous xSLBP1 in
stage VI oocytes, and the translation of the Luc-polyA mRNA
is probably activated by embryonic PABP (63). When xSLBP1
was overexpressed in the oocytes prior to injection of the
reporter mRNAs, the translation of the Luc-SL mRNA was
stimulated to a level similar to that observed with the Luc-
polyA mRNA, increasing more than 15-fold at 16 h compared
to the translation of the Luc-TL mRNA in this batch of oocytes
(Fig. 3C, middle). Note that what is shown in Fig. 3C is relative
luciferase activity. The absolute amount of activity of both
luciferases increased at each time. In contrast, when xSLBP2
protein was overexpressed, the Luc-SL and Luc-TL mRNAs
were translated to the same extent (Fig. 3C, bottom), while
translation of the Luc-polyA mRNA was not affected (data not
shown). The reduction in translation of the Luc-SL mRNA
likely reflects the ability of overexpressed xSLBP2 to compete
with the endogenous pool of xSLBP1 for the injected Luc-SL
mRNA.
To rule out the possibility that these results were due to
different stabilities of the reporter mRNAs, we measured the
levels of the reporter mRNAs with an S1 nuclease protection
assay (see Fig. 7D, lanes 1 and 2 and 13 and 14). These results
demonstrate that xSLBP1 can activate translation of a capped
reporter mRNA that ends in the histone stem-loop in frog
oocytes. In the presence of overexpressed xSLBP1, the trans-
lational efficiency of Luc-SL is similar to the translational ef-
ficiency mediated by a poly(A) tail (Fig. 3C, middle), suggest-
ing that, in frog oocytes, xSLBP1 is as effective in activating
translation as is PABP.
The N-terminal domain of xSLBP1 is required for activation
of translation. The two Xenopus SLBPs can be arbitrarily di-
vided into three domains: the RBD and the flanking N- and
C-terminal domains (Fig. 4). The Xenopus SLBPs are only
similar in the RBD, which is located in the center of each
protein (64). These domains were exchanged between the frog
SLBPs to generate six chimeras that bind the histone stem-
loop with similar affinities (26) (unpublished results). To local-
ize the region of xSLBP1 required for translation, we tested the
abilities of these chimeric proteins to stimulate translation of
the Luc-SL mRNA in vitro. A similar approach previously
allowed us to determine the regions of xSLBP1 required for
pre-mRNA processing (26).
The various xSLBP chimeras were synthesized in the RRL,
and the lysates containing these proteins was added to fresh
lysate together with the CAT mRNA competitor and either
Luc-TL or Luc-SL reporter mRNA as described in Fig. 1A. As
previously shown (Fig. 1C), xSLBP1 stimulated translation of
the Luc-SL mRNA (Fig. 5, lanes 1 and 2) while xSLBP2 did not
(Fig. 5, lanes 15 and 16). The three chimeras that contained the
amino-terminal portion of xSLBP1 (1-1-2, 1-2-1, and 1-2-2)
stimulated translation of the Luc-SL mRNA to similar extents
(Fig. 5, lanes 3 to 8). Those chimeras containing the amino-
terminal portion of xSLBP2 (2-1-1, 2-1-2, and 2-2-1) had no
effect on the translation of the Luc-SL mRNA (Fig. 5, lanes 9
to 14). Similar results were obtained both by quantifying lucif-
erase protein by PhosphorImager or luciferase activity by lu-
minometry (Fig. 5, bottom). We conclude that the N-terminal
region of xSLBP1 contains the region required for transla-
FIG. 4. Xenopus xSLBPs and the chimeric proteins. xSLBP1 and
xSLBP2 were arbitrarily divided into three domains, the central 73-
amino-acid RBD and the N- and C-terminal domains. These domains
were interchanged to give the six chimeric proteins shown at the
bottom. The activity of the proteins in processing histone pre-mRNA
in vivo and in vitro is indicated (26).
FIG. 5. Assay of the effects of xSLBP chimeras on translation in
vitro. Lysates containing the xSLBP chimeras shown in Fig. 4 were
incubated with the standard polyadenylated CAT mRNA and the
Luc-TL or Luc-SL mRNA and assayed for luciferase activity. The
reaction mixtures were analyzed by gel electrophoresis, and the pro-
teins were detected by autoradiography (top). Luciferase activity was
assayed by luminometry, and the fold activation was expressed as the
ratio of Luc-SL activity to Luc-TL activity (bottom). The bar graph
shows the averages of two experiments with two different batches of
RRL, and the error bars represent the standard deviations.
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tional activation in vitro. Similar results were obtained when
these chimeras were analyzed in vivo (data not shown).
Localization of the translation activation domain in the
amino-terminal region of xSLBP1. To demarcate the bound-
aries of the xSLBP1 translation activation domain and define a
minimal protein required for activation of translation, we gen-
erated a number of deletions in the N- and C-terminal regions
of xSLBP1 (Fig. 6A). We tested the ability of each deletion
mutant to stimulate translation of the Luc-SL mRNA both in
vitro and in vivo. A protein missing the first 68 amino acids
(68-1-1) was as effective as full-length xSLBP1 in stimulating
translation in vitro (Fig. 6B, lanes 1 to 4). Deletion of 13
additional amino acids (81-1-1) resulted in a loss of transla-
tion activation (Fig. 6B, lanes 7 and 8). Deletion of the entire
C-terminal portion of xSLBP1 (1-1-0 and 68-1-0) had no
effect on activation of translation (Fig. 6B, compare lanes 3
and 4 with lanes 5 and 6, lanes 7 and 8 with lanes 9 and 10, and
lanes 1 and 2 with lanes 11 and 12).
We tested the same deletion mutants in vivo with essentially
similar results (Fig. 7A). Mutant forms 1-1-0, 68-1-1, and
68-1-0 stimulated translation in vivo to extents similar to that
of xSLBP1, whereas the 81-1-1 deletion was inactive. We
assayed for the presence of these proteins in Xenopus oocytes
by measuring RNA binding activity (Fig. 7B) and, when pos-
sible, by Western blotting (Fig. 7C). Mutant forms 68-1-0 and
1-1-0 are not detectable by Western blotting because the an-
tibody against xSLBP1 recognizes only the C-terminal portion
of the protein. The 81-1-1 mutant form was clearly overex-
pressed (Fig. 7B, lanes 9 and 10, and C, lanes 7 and 8;) in the
oocytes. The amounts of the 68-1-1 and 68-1-0 proteins
active in stem-loop binding were greater than the store of
endogenous xSLBPs (Fig. 7B, lanes 5 to 8 versus lane 15),
although they were overexpressed to lesser extents than the
other proteins. The 131-amino-acid mutant form 68-1-0 rep-
resents the smallest xSLBP1 protein we tested that is capable
of activating translation of a reporter gene ending in the stem-
loop.
The data provided by the deletion mutants suggested that
the critical region for translation activation is located between
amino acids 69 and 81. To confirm the importance of these
residues, we deleted amino acids 69 to 81 from the full-length
protein (Fig. 6A, 13). The 13 mutant did not stimulate
translation of the Luc-SL mRNA in vitro (Fig. 6B, lanes 13 and
14) or in vivo (Fig. 7A). The 13 protein was clearly overex-
pressed in the oocytes, as shown by both mobility shift assay
(Fig. 7B, lanes 11 and 12) and Western blotting (Fig. 7C, lanes
5 and 6). Note that the deletion of 13 amino acids caused a
major change in the mobility of the protein on SDS-polyacryl-
amide gels both after synthesis in vitro (Fig. 6B, lanes 13 and
14) and after synthesis in vivo (Fig. 7C, lanes 5 and 6). xSLBP1
has aberrant mobility on SDS-PAGE (apparent molecular
mass of 45 kDa for a 31-kDa protein) (64). Deletion of these
13 amino acids resulted in mobility similar to that expected for
the 30-kDa 13 protein.
The amount of the Luc-SL and Luc-TL mRNAs present in
the oocytes after the incubation was determined by an S1
nuclease protection assay (Fig. 7D). A probe labeled in the
coding region of the Luc-SL gene is protected by the Luc-SL
mRNA to the 3 end of the mRNA and by the Luc-TL mRNA
to the place in the 3 UTR where the Luc-TL sequence differs
from the Luc-SL sequence. Since there is a single labeled
nucleotide in each probe, the intensity of the protected frag-
ment is proportional to the amount of RNA present in the
sample. The amounts of both mRNAs were similar in the
oocytes injected with each of the mutant SLBPs, demonstrat-
ing that the differences in translation efficiency were not due to
variations in reporter mRNA stability.
Amino acids 70 to 84 are essential for translation. To pre-
cisely define the amino acids in xSLBP1 required for transla-
FIG. 6. Effect of xSLBP1 deletion mutant forms on translation
activation in vitro. (A) Deletions in the amino- and carboxy-terminal
regions of xSLBP1. (B) Lysates containing the xSLBP1 deletion mu-
tant forms shown in panel A were incubated with the standard poly-
adenylated CAT mRNA and the Luc-TL or Luc-SL mRNA. Protein
synthesis (top) and luciferase activity (bottom) were assayed as de-
scribed in Fig. 1C and D, respectively. The bar graph shows the aver-
ages of two experiments with two different batches of RRL, and the
error bars represent the standard deviations.
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tion activation, we generated alanine scanning mutations in
each of which a stretch of five amino acids was replaced with
alanines spanning residues 65 to 89 (Fig. 8A), leaving the rest
of xSLBP1 intact. The effects of these mutant forms on trans-
lation activation were analyzed with both in vitro (Fig. 8B) and
in vivo (Fig. 8C) assays. All of the mutant forms were ex-
pressed to similar extents in vitro (Fig. 8B) and in vivo (Fig.
8D). Note that one of the mutant proteins, SLBP65-69/5A, when
expressed both in vitro (Fig. 8B, lanes 5 and 6) and in vivo (Fig.
8D, lanes 3 and 4), has slower mobility than full-length SLBP.
The xSLBP65-69/5A and xSLBP85-89/5A mutant proteins, which
have mutations outside the region deleted in the 13 mutant
protein, had translation activity similar to that of wild-type
xSLBP1 in vitro (Fig. 8B, lanes 5 and 6 and 13 and 14) and
in vivo (Fig. 8C). Luciferase synthesis was increased six- to
sevenfold in these experiments from the Luc-SL mRNA
compared to the Luc-TL mRNA. The xSLBP70-74/5A and
xSLBP75-79/5A mutant proteins each were inactive in transla-
tion in vitro (Fig. 8B, lanes 7 to 10) and in vivo (Fig. 8C).
Expression of xSLBP70-74/5A and xSLBP75-79/5A in oocytes re-
duced translation of the Luc-SL mRNA, consistent with these
mutant proteins competing with the endogenous xSLBP1 pro-
tein for binding of the Luc-SL mRNA but being unable to
activate translation. The xSLBP80-84/5A mutant protein has
about 50% of the activity of wild-type xSLBP1 in activation
of translation in vitro (Fig. 8B, lanes 11 and 12) and in vivo
(Fig. 8C). Thus, the 10-amino-acid region of xSLBP1 between
amino acids 70 and 80 is essential for the activation of trans-
lation of Luc-SL mRNA in both assays.
The MS2-SLBP fusion protein activates translation of Luc-
MS2 mRNA. To determine whether SLBP has to be bound to
the histone stem-loop or simply physically associated with the
mRNA to activate translation, we constructed a fusion protein
that had the entire hSLBP fused to the MS2 protein (MS2-
hSLBP). We also constructed a luciferase reporter gene that
had a binding site for the MS2 protein at the 3 end of the
mRNA. We expressed the MS2-hSLBP, the hSLBP, and the
MS2 protein in the reticulocyte lysate and tested each for the
ability to activate translation of the Luc-MS2, Luc-SL, or
Luc-TL mRNA (Fig. 9). The MS2-hSLBP fusion protein acti-
vated translation of both the Luc-MS2 and Luc-SL mRNAs
1.5- to 2-fold (range of three independent experiments),
whereas it had no effect on the translation efficiency of the
Luc-TL mRNA. The fusion of the MS2 protein to the hSLBP
reduced its activity on the Luc-SL mRNA, and the fusion
protein was equally active on the Luc-SL and Luc-MS2
mRNAs. Not surprisingly, in vitro-synthesized hSLBP failed to
affect translation of the Luc-TL and Luc-MS2 mRNAs, al-
though it activated Luc-SL mRNA translation nearly threefold.
Control protein MS2 failed to activate translation of any of the
reporter mRNAs tested (Fig. 9, lanes 1 to 3). Thus, the MS2-
hSLBP can activate translation even though the SLBP is not
directly bound to the mRNA. The reduced activity of this
hybrid protein compared with that of the hSLBP, observed
both on the Luc-SL and Luc-MS2 mRNAs, is likely due to the
reduced activity of the hybrid protein in activating translation.
Most likely, this is a nonspecific effect of the fusion of the MS2
protein to the SLBP that may well cause steric problems in
interactions with the translation initiation machinery. We have
no evidence that the SLBP RBD–stem-loop complex plays a
direct role in translation. When we expressed the SLBP-MS2
fusion in oocytes, we also saw a lower, but equivalent, activity
of this protein in activation of translation of the capped Luc-
MS2 and Luc-SL transcripts (data not shown). Thus, the trans-
lation activation region of SLBP must be localized to the
FIG. 7. Effect of xSLBP1 deletion mutant forms on translation
activation in vivo. (A) Oocytes were injected with xSLBP1 deletion mu-
tant mRNAs (Fig. 6A) or buffer at T0. At T1, they were injected with
the R-Luc-SL mRNA together with the Luc-SL or Luc-TL mRNA.
Oocytes were harvested at T2 and assayed for Renilla and firefly lucif-
erase activities as described in Fig. 3C. The results shown are the
averages of two experiments with two different batches of oocytes, with
the error bars representing the standard deviations. (B) One oocyte
equivalent of lysate from oocytes injected with mRNAs encoding the
mutant SLBPs described in panel A was mixed with 5 ng of radiola-
beled stem-loop RNA and analyzed by gel electrophoresis. The
xSLBP/SL complex was detected by autoradiography. (A) Oocytes
injected with buffer (lanes 9 to 11) or mRNAs encoding mutant SLBPs
containing the intact C-terminal region of xSLBP1 (lanes 3 to 8) were
analyzed by Western blotting as described in Fig. 3B. (B) Total RNA
from oocytes injected as described in panel A and harvested at T2 
32 h was hybridized to 3-end-radiolabeled DNA complementary to
the 3 end of Luc-SL mRNA and subjected to S1 nuclease treatment.
The protected DNA fragment was resolved by PAGE and detected by
autoradiography. The Luc-SL mRNA protects a fragment 523 nt long
that maps to the expected 3 end, whereas Luc-TL mRNA protects a
508-nt fragment that maps to the start of the loop, where the sequences
of Luc-SL and Luc-TL diverge.
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mRNA to mediate activation of translation (Fig. 3A and 9,
lanes 7 and 9 versus lane 8).
DISCUSSION
There are two classes of cellular mRNAs in metazoans that
are distinguished by their 3 ends. The bulk of the mRNAs end
in poly(A) tails, while the mRNAs from the replication-depen-
dent histone genes, the products of about 70 genes in mice (65)
and humans (2), lack poly(A) tails but end in a conserved
stem-loop. The stem-loop sequence has been conserved in the
histone mRNAs in all metazoans.
Translation of polyadenylated mRNAs in eukaryotes re-
quires both the 5 end, which contains the 7-methyl-G cap, and
the poly(A) tail (29, 58, 60). In the competition for limiting
translation initiation factors in the cell (31, 51), it is necessary
for the cap to be recognized by eIF-4E, which in turn binds to
eIF-4G, and for the poly(A) tail-bound PABP to interact with
eIF-4G, effectively circularizing the mRNA (58, 68). In this
paper, we provide evidence that efficient translation of histone
mRNA may utilize a similar mechanism; the xSLBP1 bound to
the stem-loop at the 3 end of the histone mRNA, a functional
homologue of the poly(A) tail, is essential for a high rate of
translation.
Control of gene activity during early embryogenesis requires
translation regulation of mRNAs that are synthesized and
stored in the oocyte (10, 30, 32, 53, 54, 57). This is particularly
true of organisms like Xenopus and Drosophila, where there is
no transcription in the embryo until after the midblastula tran-
sition (41, 42, 73). Histone mRNAs accumulate early in oo-
genesis and are stored for the remainder of oogenesis (72);
translation is activated during oocyte maturation (1, 71). Oo-
cyte-specific xSLBP2 plays a major role in the storage of the
histone mRNA in a silent form (64) and probably prevents
xSLBP1 (which accumulates later in oogenesis) from activating
translation of histone mRNA prior to oocyte maturation.
xSLBP1 bound to the 3 end of histone mRNA stimulates
translation. To demonstrate a role for SLBP and the stem-
loop in translation in vitro, it was necessary to establish a
system in which the added mRNAs were competing for initi-
ation factors (49) and the 3 end of the mRNA could contrib-
FIG. 8. Alanine scanning of the xSLBP1 translation activation do-
main. (A) Amino acids 65 to 89 in the N-terminal region of xSLBP1
were replaced sequentially, five residues at a time, with five alanines
(underlined). WT, wild type. (B) Lysates containing the five-alanine
substitutions shown in panel A were incubated with the standard poly-
adenylated CAT mRNA and the Luc-TL or Luc-SL mRNA. Protein
synthesis (top) and luciferase activity (bottom) were assayed as de-
scribed in Fig. 1C and D, respectively. The bar graph shows the aver-
ages of two experiments with two different batches of RRL, and the
error bars represent the standard deviations. (C) Oocytes injected at
T0 with the xSLBP1 five-alanine substitution mRNAs and then again at
T1  16 h with Luc-SL or Luc-TL mRNA in combination with R-
Luc-SL mRNA were harvested at T2  32 h, processed, and analyzed
for luciferase activity as described in Fig. 1C. The averages of two
experiments with two different batches of oocytes are shown. The error
bars represent the standard deviations. (D) A fraction corresponding
to one oocyte worth of the same lysate used for the luciferase assay of
panel C was used for detection of the xSLBP1 five-alanine substitution
mutant proteins. The Western blot shown was performed as described
previously. Oocytes injected at T0 and T1 with buffer show the level of
endogenous xSLBP1 protein (lane 13).
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ute to the translation activity. To do this, we used uncapped
reporter mRNAs, since there is a large amount of eIF-4E
activity in the reticulocyte lysates and capped mRNAs that are
not polyadenylated are translated well because of the cap (6,
24, 38, 49). We also included an excess of competitor mRNA,
a CAT mRNA that was uncapped but was polyadenylated.
Since the reticulocyte lysate does not contain significant
amounts of SLBP as assayed by mobility shift assays (66), we
were able to develop a translation system that was dependent
on exogenous SLBP. Since SLBP synthesized by in vitro trans-
lation is highly active in RNA binding and the recombinant
baculovirus SLBPs vary in activity and solubility (unpublished
results), we expressed the SLBP by translating it in the lysate
prior to addition of the reporter mRNAs.
The 3 end of the mRNA is important for translation under
these conditions. The poly(A) tail had a significant effect on
translation (Fig. 2D) as a result of the large amounts of PABP
present in the lysate, as has been previously reported for the
reticulocyte lysate under competitive conditions (6, 28, 40).
The translation of the Luc-SL mRNA was specifically stimu-
lated by the addition of either xSLBP1 (Fig. 1D) or hSLBP
(Fig. 2A). Neither protein affected translation of an equally
stable reporter mRNA that ended in a stem-loop structure that
does not bind SLBP (Luc-TL).
SLBP enhances translation of histone mRNA via a novel
domain. In the heterologous RRL, xSLBP1 activated transla-
tion while xSLBP2 had no effect on translation of reporter
mRNAs ending in the stem-loop. We used this assay to deter-
mine the precise region of xSLBP1 required for translation in
the reticulocyte lysate. The 15 amino acids in the N-terminal
region of xSLBP1 required for translation are identical in
xSLBP1 and the mammalian SLBPs, consistent with this acti-
vation being physiologically important in mammalian cells.
There is not a similar sequence in the Drosophila (55) or C.
elegans SLBP (33, 37), and the Drosophila SLBP is not active in
translation of the Luc-SL mRNA in the reticulocyte lysate
(unpublished results).
One of the limitations of the in vitro assay is that it measures
the effect of xSLBP1 on translation of uncapped mRNAs. We
developed an in vivo assay to demonstrate that xSLBP1 can
activate translation of capped reporter mRNAs in frog oocytes.
This assay is complicated by the presence of some xSLBP1 in
the frog oocyte that is capable of binding exogenous mRNA. In
oocytes that do not express exogenous SLBP, the luciferase
mRNA ending in the stem-loop (Luc-SL) was translated more
efficiently than the Luc-TL mRNA that does not bind SLBP
(Fig. 3C, top). Again, the Luc-polyA mRNA was translated
better than the other reporter mRNAs, probably because of
the large amount of free embryonic PABP in the oocyte (63).
Overexpression of xSLBP1 in oocytes stimulated translation of
the Luc-SL mRNA up to the same level as the Luc-polyA
mRNA, suggesting that xSLBP1 may be a functional homo-
logue of PABP. The same 15-amino-acid region was required
for complete activation of translation in vitro and in vivo (Fig.
8B and C).
Role of xSLBP2 in histone mRNA translation activity. The
other SLBP present in frog oocytes, xSLBP2, was inactive in
translation, as predicted from its proposed role in storing his-
tone mRNA in an inactive mRNP (64). Is xSLBP2 a transla-
tional repressor, or does it simply serve to keep xSLBP1 from
binding the reporter mRNA? It is not possible to definitively
answer this question on the basis of the data presented here.
However, it is clear that xSLBP2 had no effect on the basal
translation of Luc-SL mRNA in the reticulocyte lysate (Fig.
2D). Since this is a heterologous artificial system, any inhibitor
activity might not be observed, particularly if translational si-
lencing requires other oocyte-specific factors. Expression of
xSLBP2 does reduce the translation of the Luc-SL mRNA in
oocytes (Fig. 3C). However, this effect could be explained by
the exogenous xSLBP2 competing with endogenous xSLBP1
for binding to the Luc-SL mRNA. The reduction observed is to
the same “basal” level of translation observed with the Luc-TL
mRNA, which does not bind either xSLBP. In addition, ex-
pression of xSLBP1 mutant proteins inactive in translation (the
13 and 81-1-1 proteins or some of the alanine scanning
mutants) also reduced the translation of the Luc-SL mRNA,
consistent with xSLBP2 being a passive “masker” of translation
in both of these assays.
It is certainly possible that storage of histone mRNA in a
translationally inactive form might require factors other than
xSLBP2. Repression of translation of other oocyte mRNAs
requires the FRGY2 protein (36), and the stored inactive
mRNP is assembled in a process that depends on the coupling
of transcription and processing of the mRNA (7). There are
many endogenous mRNAs that are not translated efficiently in
frog oocytes but, instead, are stored in an inactive mRNP and
contain short poly(A) tails (13). Translation of these mRNAs
FIG. 9. Translation activation by MS2-hSLBP fusion protein in
vitro. Lysates containing MS2 (lanes 1 to 3), MS2-hSLBP fusion pro-
tein (lanes 4 to 6), or hSLBP (lanes 7 to 9) were incubated with the
standard polyadenylated CAT mRNA and the Luc-TL, Luc-SL, or
Luc-MS2 mRNA. Protein synthesis (top) and luciferase activity (bot-
tom) were assayed as described in Fig. 3C and D, respectively. The bar
graph shows the averages of three experiments with two different
batches of RRL, and the error bars represent the standard deviations.
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may be actively inhibited by a complex bound to the cytoplas-
mic polyadenylation element, consisting of cytoplasmic poly-
adenylation element B and maskin (21, 53), as well as other
general mRNA binding proteins (20, 53). In this complex,
maskin competes with eIF-4G for binding to eIF-4E, ulti-
mately preventing the eIF3-associated 40S ribosomal subunit
from binding to the mRNA.
Mechanisms for activation of histone mRNA translation. It
is possible that the stored histone mRNA is silenced by other
factors in addition to xSLBP2. However, it is likely that trans-
lational activation of histone mRNA requires the recruitment
of xSLBP1 to the mRNA. In addition to exchange of the
xSLBPs, the histone mRNAs undergo other structural changes
during oogenesis, the addition of a short poly(A) tail early in
oogenesis and its subsequent removal at oocyte maturation (3).
This modification may also play a role in translational control
in vivo.
The role of the 3 end in translation initiation of polyade-
nylated mRNAs and in rotavirus mRNAs is reasonably well
understood. PABP binds to eIF-4G through a region compris-
ing RRM1 and RRM2 in the N-terminal domain of PABP (25,
29), resulting in circularization of the mRNA. This event pro-
motes formation of the preinitiation complex, as well as recy-
cling of ribosomes from the termination site (6, 27, 67). Rota-
virus mRNAs end in a consensus sequence that is bound by the
NSP3 viral protein (48). The NSP3 protein interacts with the
40-amino-acid PABP binding domain in eIF-4G, with a motif
that has no obvious similarity to the eIF-4G binding domain in
PABP (47, 62), although it binds to the same site (19). There
is no similarity between the sequence required for translation
activation by SLBP and the eIF-4G binding sequences in either
PABP or NSP3. Further data are required to determine wheth-
er SLBP promotes translation by interacting directly with the
translation initiation complex, possibly by binding eIF-4G. Al-
ternatively, SLBP may play a pivotal role in recruiting other
factors required for activation of translation via mRNA circu-
larization.
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